ASTELLAS PHARMA UNSP.ADR (YPHA) — Financial Flexibility Index
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Financial Flexibility Index of 0.14x as of March 2025. Free cash flow of €251.84 Billion (operating CF €194.51 Billion minus capex €57.33 Billion) represents 0% of total liabilities (€1.83 Trillion). Check YPHA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ASTELLAS PHARMA UNSP.ADR Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of ASTELLAS PHARMA UNSP.ADR.
Annual Financial Flexibility Index for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year free cash flow to debt coverage for ASTELLAS PHARMA UNSP.ADR. Explore cash flow to debt ratio of ASTELLAS PHARMA UNSP.ADR to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | €251.84 Billion | €194.51 Billion | €1.83 Trillion | ▲ +6.7% |
| 2024 | 0.13x | €254.97 Billion | €172.47 Billion | €1.97 Trillion | ▼ -70.6% |
| 2023 | 0.44x | €416.31 Billion | €327.77 Billion | €948.56 Billion | ▲ +14.6% |
| 2022 | 0.38x | €333.89 Billion | €257.44 Billion | €872.09 Billion | — |